Markel Insurance, the insurance operations within Markel Group Inc. (NYSE:MKL), announced on October 28, 2026, that it has entered into an adverse development cover reinsurance agreement with Enstar covering a portfolio of run-off global reinsurance and certain exited insurance lines.

Key Highlights

  • Subject reserves of $4.8 billion are covered under the agreement, spanning underwriting years 2025 and prior.
  • Markel retains the first $2.6 billion of subject reserves and retrocedes the next $2.3 billion to Enstar.
  • Adverse loss development coverage of $1.2 billion is provided above the $4.8 billion of subject reserves.
  • Risk premium of $120 million will be paid by Markel to Enstar under the transaction terms.
  • Net impact on underwriting results in the fourth quarter of 2026 is expected to be immaterial, according to the filing.
  • Closing is subject to regulatory approval and other customary conditions, expected by the end of the fourth quarter of 2026.
  • Enstar's subsidiary Cavello Bay Reinsurance Limited, rated 'A' for financial strength by S&P, will provide the coverage.

Structure and Scope of the Markel-Enstar Reinsurance Agreement

According to the filing, Markel Insurance entered into an adverse development cover reinsurance agreement with Enstar that addresses a portfolio consisting of its run-off Global Reinsurance division and certain exited lines within its global insurance operations. The exited lines specifically identified in the filing include risk-managed professional liability, architects and engineers, and other run-off lines. Markel, as a leading global specialty insurer, writes across a broad array of specialty insurance needs, and the agreement is designed to provide additional certainty as these particular legacy liabilities continue to run off.

The filing states that Markel will retain the first $2.6 billion of the $4.8 billion in subject reserves and retrocede the next $2.3 billion to Enstar. Beyond those subject reserves, Markel receives an additional $1.2 billion of adverse loss development coverage. The filing notes that this coverage "reduces the level of prudency management requires in its best estimate of ultimate losses," and that the net impacts of the transaction are expected to have an immaterial impact on underwriting results in the fourth quarter of 2026. Markel will maintain claims control under the agreement.

Simon Wilson, Chief Executive Officer of Markel Insurance, is quoted in the filing as saying the transaction "provides additional certainty as these liabilities continue to run off and allows us to continue our focus on growing our core specialty insurance business." The filing characterizes the agreement as advancing strategic priorities, enhancing financial flexibility, and strengthening Markel's ability to deliver long-term value. The filing contains forward-looking statements regarding the expected timing and completion of the transaction, receipt of regulatory approval, and expectations regarding ultimate losses, all of which the company's own cautionary language identifies as subject to risks and uncertainties that could cause actual results to differ materially.

What Was Disclosed

Markel Group Inc. (NYSE:MKL) disclosed via an 8-K press release dated October 28, 2026, that Markel Insurance and Enstar have executed an adverse development cover reinsurance agreement with $4.8 billion in subject reserves, a $1.2 billion loss development layer, and a $120 million risk premium, with closing expected by end of the fourth quarter of 2026.